- Home
- WDH vs NRIX Comparison
WDH vs NRIX Comparison
Compare WDH & NRIX Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- WDH
- NRIX
- Stock Information
- Founded
- WDH 2016
- NRIX 2009
- Country
- WDH China
- NRIX United States
- Employees
- WDH N/A
- NRIX N/A
- Industry
- WDH Specialty Insurers
- NRIX Biotechnology: Pharmaceutical Preparations
- Sector
- WDH Finance
- NRIX Health Care
- Exchange
- WDH Nasdaq
- NRIX Nasdaq
- Market Cap
- WDH 651.0M
- NRIX 728.6M
- IPO Year
- WDH 2021
- NRIX 2020
- Fundamental
- Price
- WDH $1.85
- NRIX $9.02
- Analyst Decision
- WDH
- NRIX Strong Buy
- Analyst Count
- WDH 0
- NRIX 14
- Target Price
- WDH N/A
- NRIX $29.07
- AVG Volume (30 Days)
- WDH 377.7K
- NRIX 766.8K
- Earning Date
- WDH 09-04-2025
- NRIX 10-10-2025
- Dividend Yield
- WDH 3.17%
- NRIX N/A
- EPS Growth
- WDH 71.77
- NRIX N/A
- EPS
- WDH 0.17
- NRIX N/A
- Revenue
- WDH $416,345,794.00
- NRIX $88,381,000.00
- Revenue This Year
- WDH N/A
- NRIX $74.59
- Revenue Next Year
- WDH $9.29
- NRIX N/A
- P/E Ratio
- WDH $11.16
- NRIX N/A
- Revenue Growth
- WDH 9.39
- NRIX 41.86
- 52 Week Low
- WDH $0.97
- NRIX $8.18
- 52 Week High
- WDH $2.18
- NRIX $29.56
- Technical
- Relative Strength Index (RSI)
- WDH 54.96
- NRIX 40.16
- Support Level
- WDH $1.82
- NRIX $8.90
- Resistance Level
- WDH $1.92
- NRIX $10.13
- Average True Range (ATR)
- WDH 0.10
- NRIX 0.48
- MACD
- WDH 0.00
- NRIX 0.02
- Stochastic Oscillator
- WDH 29.77
- NRIX 13.82
About WDH Waterdrop Inc. (each representing the right to receive 10)
Waterdrop Inc is a technology platform dedicated to insurance and healthcare service. The Company is mainly engaged in operating an independent third-party insurance platform dedicated to providing insurance and healthcare service. The Company's main businesses are the insurance marketplace, medical crowdfunding, and mutual aid. The insurance marketplace business is collaborated with insurance carriers to offer health and life insurance products to ensure a smooth and friendly user experience throughout the process from underwriting to claim services. The medical crowdfunding business enabled people with medical costs.
About NRIX Nurix Therapeutics Inc. Common stock
Nurix Therapeutics Inc is a biopharmaceutical company focused on the discovery, development and commercialization of oral, small molecule therapies designed to modulate cellular protein levels as a novel treatment approach for cancer and immune disorders. The company's pipeline comprises targeted protein degraders of Brutons tyrosine kinase, or BTK, a B-cell signaling protein, and inhibitors of Casitas B-lineage lymphoma proto-oncogene-B, or CBL-B, an E3 ligase that regulates T cell activation. Its drug candidate from protein degradation portfolio, NX-2127, is an orally available BTK degrader for the treatment of relapsed or refractory B-cell malignancies.